Vuzix Blade Selected as the Smart Glasses Companion for X.Labs’ New AI Screening and Temperature Detection System Feevr

ROCHESTER, N.Y., March 20, 2020 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that the Vuzix Blade  ® Smart Glasses have been selected by X.Labs, developer of SWORD weapon detection system, as the optional smart glasses companion for Feevr.  Feevr is a quick and effective artificial intelligence (AI) based system for screening and detecting individuals in a crowd that have an elevated temperature. 

Vuzix has received an order, with an initial payment upfront, from X.Labs and will immediately ship 100 Vuzix Blade Smart Glasses to support the launch of Feevr.  X.Labs expects to begin shipping Feevr units to customers beginning March 26, 2020

Feevr describes it product as a completely mobile platform that utilizes a thermal imaging camera with best-in-class thermal sensitivity and an AI-based mobile app integrated with an Android device. Feevr’s non-contact-based solution automatically provides a discreet alert when a scanned individual’s temperature exceeds a predetermined threshold. The Feevr solution thus enables its users to efficiently and effectively identify individuals who may require further medical examination as an elevated temperature is one of the key indicators of an infectious disease such as COVID-19 (Coronavirus).

When Feevr is paired and integrated with the Vuzix Blade, users will receive a real-time alert on the heads-up display of the Vuzix smart glasses, allowing the glasses wearer to stay engaged with their environment while also simultaneously receiving critical alerts from Feevr.

“Vuzix Blade provides a see-through display that allows our customers to receive real-time alerts from our Feevr solution while staying engaged with their environment,” said Barry Oberholzer, Founder and CEO of X.Labs. 

“Vuzix is excited to be working with the X.Labs to provide a smart glasses solution that can deliver critical information on demand as needed to Feevr users,” said Paul Travers, President and Chief Executive Officer at Vuzix. 

About Vuzix Corporation

Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company’s products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 150 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan.  For more information, visit Vuzix websiteTwitter and Facebook pages.

Forward-Looking Statements Disclaimer

Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to our Vuzix Blade Smart Glasses and our business relationship with X.Labs, future business and among other things the Company’s leadership in the Smart Glasses and AR display industry. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Media and Investor Relations Contact:

Ed McGregor, Director of Investor Relations, Vuzix Corporation ed_mcgregor@vuzix.com Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/vuzix-blade-selected-as-the-smart-glasses-companion-for-xlabs-new-ai-screening-and-temperature-detection-system-feevr-301027544.html

SOURCE Vuzix Corporation

Staff

Recent Posts

Methodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazine

MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…

2 days ago

Hospital PMI® at 55.8%; June 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…

2 days ago

KORE Helps mCare Digital Launch the Next Generation of Personal Emergency Technology

mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…

2 days ago

Cosmo Shareholders Approved All Resolutions Proposed by the Board of Directors at Extraordinary General Meeting

Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…

2 days ago

Hitachi’s Holography Electron Microscope Attains Unprecedented Resolution

Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…

2 days ago

Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds

Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…

2 days ago